Page last updated: 2024-09-02

2'-5'-oligoadenylate trimer and 2019 Novel Coronavirus Disease

2'-5'-oligoadenylate trimer has been researched along with 2019 Novel Coronavirus Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Arumugam, T; Gokul, A; Ramsuran, V1
Davies, EL; Hughes, J; Jackson Ireland, H; Li, Z; Ludlam, EM; Lytras, S; Sims, A; Stewart, DG; Sugrue, E; Swingler, S; Wickenhagen, A; Wilson, SJ1
Bravo, JPK; Brouns, SJJ; Hofstra, LM; Keijser, BJF; Ossendrijver, M; Prinsen, SHP; Schoen, CD; Shinkai, A; Staals, RHJ; Steens, JA; Taylor, DW; van der Oost, J; Zhu, Y1

Reviews

1 review(s) available for 2'-5'-oligoadenylate trimer and 2019 Novel Coronavirus Disease

ArticleYear
Genetic Ethnic Differences in Human 2'-5'-Oligoadenylate Synthetase and Disease Associations: A Systematic Review.
    Genes, 2023, 02-19, Volume: 14, Issue:2

    Topics: Adenine Nucleotides; COVID-19; Humans; Oligoribonucleotides; SARS-CoV-2

2023

Other Studies

2 other study(ies) available for 2'-5'-oligoadenylate trimer and 2019 Novel Coronavirus Disease

ArticleYear
Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication.
    PLoS biology, 2023, Volume: 21, Issue:11

    Topics: 2',5'-Oligoadenylate Synthetase; Animals; Chiroptera; COVID-19; Humans; Phylogeny; SARS-CoV-2

2023
SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation.
    Nature communications, 2021, 08-19, Volume: 12, Issue:1

    Topics: Adenine Nucleotides; COVID-19; CRISPR-Associated Proteins; CRISPR-Cas Systems; Diagnostic Tests, Routine; Humans; Oligoribonucleotides; Ribonucleases; RNA, Bacterial; SARS-CoV-2

2021